Ravi Vij

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 31 papers. Top paper: “Initial genome sequencing and analysis of multiple myeloma”.

Initial genome sequencing and analysis of multiple myeloma

Nature(2011)10.1038/nature09837

N/A

1.1DataRank · unranked

1438 citations

Michael S. Lawrence, Jonathan J. Keats, Kristian Cibulskis, Carrie Sougnez, Anna C. Schinzel +51 more

A meta-analysis of genome-wide association studies of multiple myeloma among men and women of African ancestry

Blood Advances(2020)10.1182/bloodadvances.2019000491

N/A

1.1DataRank · unranked

31 citations

Niels Weinhold, Gregory Song, Kristin A. Rand, David Van Den Berg, Amie E. Hwang +65 more

Phase 3 randomized trial of chemotherapy with or without oblimersen in older AML patients: CALGB 10201 (Alliance)

Blood Advances(2021)10.1182/bloodadvances.2021004233

N/A

1.0DataRank · unranked

30 citations

Guido Marcucci, Jun Yin, William Blum, Wendy Stock, Jessica Kohlschmidt +15 more

VLA4-Targeted Nanoparticles Hijack Cell Adhesion–Mediated Drug Resistance to Target Refractory Myeloma Cells and Prolong Survival

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-20-2839

N/A

0.948DataRank · unranked

27 citations

Michael J. Scott, John S. Allen, Xiaoxia Yang, Grace Cui, Dipanjan Pan +12 more

Epigenetic regulation during cancer transitions across 11 tumour types

Nature(2023)10.1038/s41586-023-06682-5

N/A

0.803DataRank · unranked

211 citations

Alla Y. Karpova, Wen-Wei Liang, Alexander Strzalkowski, Siqi Chen, Yize Li +39 more

Clinical response and pathway-specific correlates following TIGIT–LAG3 blockade in myeloma: the MyCheckpoint randomized clinical trial

Nature Cancer(2024)10.1038/s43018-024-00818-w

N/A

0.727DataRank · unranked

20 citations

Alexander M. Lesokhin, Barry Paul, Jonathan L. Kaufman, Matthew J. Pianko, Noa Biran +9 more

CS1 CAR-T targeting the distal domain of CS1 (SLAMF7) shows efficacy in high tumor burden myeloma model despite fratricide of CD8+CS1 expressing CAR-T cells

Leukemia(2022)10.1038/s41375-022-01559-4

N/A

0.604DataRank · unranked

55 citations

Julie Ritchey, Matthew Cooper, Jessica Niswonger, Luisalberto Gonzalez, Emily Street +12 more

The characteristics, treatment patterns, and outcomes of older adults aged 80 and over with multiple myeloma

Journal of Geriatric Oncology(2020)10.1016/j.jgo.2020.03.005

N/A

0.449DataRank · unranked

19 citations

Nicole Foley, Sonja Zweegman, Ravi Vij, Tanya M. Wildes, Mark A. Fiala

A pilot study of 3D tissue-engineered bone marrow culture as a tool to predict patient response to therapy in multiple myeloma

Scientific Reports(2021)10.1038/s41598-021-98760-9

N/A

0.425DataRank · unranked

16 citations

Amanda Jeske, Pilar de la Puente, Jennifer Sun, Mark A. Fiala, Feda Azab +6 more

Ixazomib, lenalidomide and dexamethasone consolidation with randomized ixazomib or lenalidomide maintenance after autologous transplant in newly diagnosed multiple myeloma

Leukemia(2022)10.1038/s41375-022-01691-1

N/A

0.416DataRank · unranked

15 citations

Thomas G. Martin, Nitya Nathwani, Mark A. Fiala, Michael P. Rettig, Feng Gao +10 more

Long-Term Follow-up of CALGB (Alliance) 100001: Autologous Followed by Nonmyeloablative Allogeneic Transplant for Multiple Myeloma

Biology of Blood and Marrow Transplantation(2020)10.1016/j.bbmt.2020.03.028

N/A

0.351DataRank · unranked

6 citations

Vera J. Suman, Kouros Owzar, Katelyn Santo, Don M. Benson, Thomas C. Shea +10 more

Memory-like NK cell differentiation, inhibitory NKG2A blockade, and improved recognition via antibody or CAR engineering combine to enhance NK cell attack against multiple myeloma

The Journal of Immunology(2025)10.1093/jimmun/vkae004

N/A

0.269DataRank · unranked

5 citations

Nancy D. Marín, Sadia Afrin, Pamela Wong, Jennifer Tran, Miriam T. Jacobs +23 more

Alemtuzumab in frontline therapy of adult acute lymphoblastic leukemia: Results of Cancer and Leukemia Group B 10102 (Alliance), a phase 1/2 study

Cancer(2025)10.1002/cncr.35750

N/A

0.216DataRank · unranked

3 citations

Jun Yin, Gerard Lozanski, Emily Curran, Gregory Malnassy, Krzysztof Mrózek +15 more

Continuous Elotuzumab, Pomalidomide, and Dexamethasone Maintenance Following Second Autologous Transplantation for Multiple Myeloma: Results of a Prospective Phase 2 Multicenter Trial

Transplantation and Cellular Therapy(2023)10.1016/j.jtct.2023.09.014

N/A

0.104DataRank · unranked

1 citations

Mark A. Fiala, Marie Kirchmeyer, Jeffrey King, Feng Gao, Mark A. Schroeder +5 more

A phase I trial evaluating the effects of plerixafor, G-CSF, and azacitidine for the treatment of myelodysplastic syndromes

Leukemia & lymphoma/Leukemia and lymphoma(2021)10.1080/10428194.2021.1872068

N/A

0DataRank · unranked

8 citations

Michael P. Rettig, Theresa Fletcher, Julie Ritchey, Leah Gehrs, Kyle McFarland +15 more

The Role of Donor Lymphocyte Infusion (DLI) in Post-Hematopoietic Cell Transplant (HCT) Relapse for Chronic Myeloid Leukemia (CML) in the Tyrosine Kinase Inhibitor (TKI) Era

Biology of Blood and Marrow Transplantation(2020)10.1016/j.bbmt.2020.02.006

N/A

0DataRank · unranked

24 citations

Ying Liu, Zhen‐Huan Hu, Kirsten M. Williams, Hillard M. Lazarus, Ravi Vij +31 more

Ablation of VLA4 in multiple myeloma cells redirects tumor spread and prolongs survival

Scientific Reports(2022)10.1038/s41598-021-03748-0

N/A

0DataRank · unranked

23 citations

Chantiya Chanswangphuwana, Nicholas S. Cho, Francesca Fontana, Dolonchampa Maji, Julie Ritchey +10 more

Risk Factors for Graft-versus-Host Disease in Haploidentical Hematopoietic Cell Transplantation Using Post-Transplant Cyclophosphamide

Biology of Blood and Marrow Transplantation(2020)10.1016/j.bbmt.2020.05.001

N/A

0DataRank · unranked

66 citations

Armin Rashidi, Tao Wang, Michael Hemmer, Margaret L. MacMillan, Joseph Pidala +66 more

Motixafortide and G-CSF to mobilize hematopoietic stem cells for autologous transplantation in multiple myeloma: a randomized phase 3 trial

Nature Medicine(2023)10.1038/s41591-023-02273-z

N/A

0DataRank · unranked

76 citations

Michael P. Rettig, Reyka G. Jayasinghe, Keith Stockerl‐Goldstein, Sarah Larson, Illes Arpad +27 more

Phase I-II Trial of Early Azacitidine after Matched Unrelated Donor Hematopoietic Cell Transplantation

Transplantation and Cellular Therapy(2023)10.1016/j.jtct.2023.08.017

N/A

0DataRank · unranked

2 citations

Jaebok Choi, Matthew Cooper, Jeffrey King, Mark A. Fiala, Jingxia Liu +13 more

Racial Disparities in the Utilization of Novel Agents for Frontline Treatment of Multiple Myeloma

Clinical Lymphoma Myeloma & Leukemia(2020)10.1016/j.clml.2020.04.018

N/A

0DataRank · unranked

22 citations

Tanya M. Wildes, Ravi Vij, Mark A. Fiala

A meta-analysis of genome-wide association studies of multiple myeloma among men and women of African ancestry

UNC Libraries(2024)10.17615/ct6n-5k64

N/A

0DataRank · unranked

0 citations

David V. Conti, J Mehta, Thomas G. Martin, Kenneth C. Anderson, Song, G.C. +65 more

Chimeric antigen receptor T‐cell therapy for high‐grade B‐cell lymphoma NOS

British Journal of Haematology(2025)10.1111/bjh.70020

N/A

0DataRank · unranked

2 citations

Kwang Woo Ahn, Jinalben Patel, Qinghua Lian, Muhammad Bilal Abid, Ahmed Al Nughmush +18 more

A Phase II Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate E-Selectin Inhibition with Uproleselan to Reduce Gastrointestinal Toxicity During Autologous Hematopoietic Cell Transplantation for Multiple Myeloma

Transplantation and Cellular Therapy(2025)10.1016/j.jtct.2025.11.007

N/A

0DataRank · unranked

1 citations

Keith Stockerl-Goldstein, Meaghan Ryan, Feng Gao, Brandon Christen, Chris Mayeski +6 more

Investigation of lncRNA expression in newly diagnosed multiple myeloma reveals a LINC01432-CELF2 axis as an inhibitor of apoptosis

Oncogenesis(2025)10.1038/s41389-025-00579-w

N/A

0DataRank · unranked

1 citations

Prasanth Thunuguntla, Dhanusha Duraiyan, Alani Perkin, Katelyn Bagwill, Savannah Gonzales +19 more

Longitudinal Profiling of Tumor and Immune Compartments Uncovers Patterns of Dysregulation and Associations with Response in Multiple Myeloma

Blood Cancer Discovery(2025)10.1158/2643-3230.bcd-25-0205

N/A

0DataRank · unranked

0 citations

William Pilcher, Marina E. Michaud, Chaitanya R. Acharya, Sarthak Satpathy, Edgar Gonzalez‐Kozlova +31 more

A Meta-analysis of Multiple Myeloma Risk Regions in African and European Ancestry Populations Identifies Putatively Functional Loci

UNC Libraries(2020)10.17615/hhzp-hr83

N/A

0DataRank · unranked

0 citations

Elad Ziv, Wendy Cozen, Andrew F. Olshan, Nathaniel Rothman, Thomas G. Martin +95 more

Characterization of Germline Variants in Multiple Myeloma

Blood(2018)10.1182/blood-2018-99-118673

N/A

0DataRank · unranked

0 citations

Qingsong Gao, Kuan-lin Huang, Steven M. Foltz, Justin King, Mark A. Fiala +7 more

Phase II Study of Allogeneic Transplantation for Older Patients With Acute Myeloid Leukemia in First Complete Remission Using a Reduced-Intensity Conditioning Regimen: Results From Cancer and Leukemia Group B 100103 (Alliance for Clinical Trials in Oncology)/Blood and Marrow Transplant Clinical Trial Network 0502

UNC Libraries(2020)10.17615/d8vv-vc17

N/A

0DataRank · unranked

0 citations

William Blum, Flora Mulkey, Richard M. Stone, Shelly Carter, Charles Linker +15 more

Nanoparticle T-cell engagers as a modular platform for cancer immunotherapy

Leukemia(2021)10.1038/s41375-021-01127-2

N/A

0DataRank · unranked

63 citations

Jennifer Sun, Katherine Wasden, Nicole Guenthner, Julie O’Neal, Barbara Muz +7 more

Tumor microenvironment-targeted nanoparticles loaded with bortezomib and ROCK inhibitor improve efficacy in multiple myeloma

Nature Communications(2020)10.1038/s41467-020-19932-1

N/A

0DataRank · unranked

75 citations

Kinan Alhallak, Jennifer Sun, Kathleen Duncan, Feda Azab, Gail Sudlow +20 more